CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis

Cancer Research

Volumn 69, Issue 12, 2009, Pages 5194-5201

  Wang, Yu ^a   Li, Jisheng ^b   Cui, Yan ^b   Li, Ting ^a   Ka, Man Ng ^b   Geng, Hua ^b   Li, Henan ^a   Shu, Xing Sheng ^b   Li, Hongyu ^b   Liu, Wei ^a   Luo, Bing ^c   Zhang, Qian ^d   Mok, Tony Shu Kam ^b   Zheng, Wei ^b   Qiu, Xiaoyan ^a   Srivastava, Gopesh ^e   Yu, Jun ^f   Sung, Joseph J Y ^f   Chan, Anthony T C ^b   Ma, Dalong ^a   Tao, Qian ^b   Han, Wenling ^a   more..

^a PEKING UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CKLF LIKE MARVEL TRANSMEMBRANE DOMAIN CONTAINING MEMBER 3 PROTEIN; CKLF LIKE MARVEL TRANSMEMBRANE DOMAIN CONTAINING MEMBER 4 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL VIABILITY; CHROMOSOME 16Q; COLON CARCINOMA; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; ENZYME ACTIVATION; EPIGENETICS; ESOPHAGUS CARCINOMA; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOCUS; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; CHEMOKINES; CHROMOSOMES, HUMAN, PAIR 16; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; FLOW CYTOMETRY; GENE SILENCING; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 67449127092     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3694     Document Type: Article

References (38)

1. Chowdhury MH, Nagai A, Terashima M, et al. Chemokine-like factor expression in the idiopathic inflammatory myopathies. Acta Neurol Scand 2008;118:106-114
2. Han W, Lou Y, Tang J, et al. Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity. Biochem J 2001;357:127-135 (Pubitemid 32642910)
3. Han W, Ding P, Xu M, et al. Identification of eight genes encoding chemokine-like factor superfamily members 1-8 (CKLFSF1-8) by in silico cloning and experimental validation. Genomics 2003;81:609-617 (Pubitemid 36637016)
4. Jin C, Ding P, Wang Y, Ma D. Regulation of EGF receptor signaling by the MARVEL domain-containing protein CKLFSF8. FEBS Lett 2005;579:6375-6382 (Pubitemid 41612155)
5. Li D, Jin C, Yin C, et al. An alternative splice form of CMTM8 induces apoptosis. Int J Biochem Cell Biol 2007;39:2107-2119 (Pubitemid 47369243)
6. Shao L, Cui Y, Li H, et al. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines. Clin Cancer Res 2007;13:5756-5762 (Pubitemid 47583900)
7. Wang Y, Li T, Qiu X, et al. CMTM3 can affect the transcription activity of androgen receptor and inhibit the expression level of PSA in LNCaP cells. Biochem Biophys Res Commun 2008;20:371:54-58
8. Caldeira JR, Prando EC, Quevedo FC, Neto FA, Rainho CA, Rogatto SR. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer 2006;6:48. (Pubitemid 47202074)
9. Chan KY, Lai PB, Squire JA, et al. Positional expression profiling indicates candidate genes in deletion hotspots of hepatocellular carcinoma. Mod Pathol 2006;19:1546-1554 (Pubitemid 44789922)
10. Li C, Berx G, Larsson C, et al. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes Cancer 1999;24:175-182 (Pubitemid 29070155)
11. Marchong MN, Chen D, Corson TW, et al. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma. Mol Cancer Res 2004;2:495-503. (Pubitemid 39281731)
12. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006;6:107-116
13. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-428 (Pubitemid 34587077)
14. Vermeulen K, Van Bockstaele DR, Berneman ZN. Apoptosis: mechanisms and relevance in cancer. Ann Hematol 2005;84:627-639
15. Gopisetty G, Ramachandran K, Singal R. DNA methylation and apoptosis. Mol Immunol 2006;43:1729-1740
16. Ying J, Srivastava G, Hsieh WS, et al. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 2005;11:6442-6449 (Pubitemid 41338980)
17. Qiu GH, Tan LK, Loh KS, et al. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and geneticmechanisms in nasopharyngeal carcinoma. Oncogene 2004;23:4793-4806 (Pubitemid 38859468)
18. Cui Y, Ying Y, van HA, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS ONE 2008;3:e2990.
19. Seng TJ, Low JS, Li H, et al. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation. Oncogene 2007;26:934-944 (Pubitemid 46245732)
20. Zhong J, Wang Y, Qiu X, et al. Characterization and expression profile of CMTM3/CKLFSF3. J Biochem Mol Biol 2006;39:537-545 (Pubitemid 44714534)
21. Ying J, Li H, Chen YW, Srivastava G, Gao Z, Tao Q. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor. Blood 2007;110:4130-4132 (Pubitemid 350248475)
22. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826
23. Tao Q, Swinnen LJ, Yang J, Srivastava G, Robertson KD, Ambinder RF. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. Am J Pathol 1999;155:619-625 (Pubitemid 29370411)
24. Tao Q, Huang H, Geiman TM, et al. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 2002;11:2091-2102 (Pubitemid 34993997)
25. i. J Biol Chem 1992;267:7545-7552
26. Lambeth JD, Burnham DN, Tyagi SR. Sphinganine effects on chemoattractant-induced diacylglycerol generation, calcium fluxes, superoxide production, and on cell viability in the human neutrophil. Delivery of sphinganine with bovine serum albumin minimizes cytotoxicity without affecting inhibition of the respiratory burst. J Biol Chem 1988;263:3818-3822 (Pubitemid 18078973)
27. 2-Macroglobulin functions as a cytokine carrier to induce nitric oxide synthesis and cause nitric oxide-dependent cytotoxicity in the RAW 264.7 macrophage cell line. J Biol Chem 1995;270:21919-21927
28. Wang Y, Li X, Wang L, et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 2004;117:1525-1532 (Pubitemid 38559827)
29. Rehm M, Dussmann H, Janicke RU, Tavare JM, Kogel D, Prehn JH. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J Biol Chem 2002;277:24506-24514 (Pubitemid 34951976)
30. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316
31. Kittler R, Putz G, Pelletier L, et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 2004;432:1036-1040 (Pubitemid 40052235)
32. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001;1:157-162 (Pubitemid 33741891)
33. Paz MF, Wei S, Cigudosa JC, et al. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet 2003;12:2209-2219 (Pubitemid 37107311)
34. Smiraglia DJ, Rush LJ, Fruhwald MC, et al. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001;10:1413-1419 (Pubitemid 32640670)
35. Ying J, Poon FF, Yu J, et al. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers. Br J Cancer 2009;100:663-669
36. Tait SW, Green DR. Caspase-independent cell death: leaving the set without the final cut. Oncogene 2008;27:6452-6461
37. Broker LE, Kruyt FA, Giaccone G. Cell death independent of caspases: a review. Clin Cancer Res 2005;11:3155-3162 (Pubitemid 40627860)
38. Shimada Y, Imamura M, Wagata T, et al. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-284